Error: Could not add to watchlist. X

Q Therapeutics Inc

+ Watchlist
QCEL:US
NASDAQ CM
Pending Listing
QCEL:US is pending Listing
USD
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding (m)
30.827
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Q Therapeutics, Inc. develops cell-based therapeutics. The Company focuses on developing novel products to treat amyotrophic lateral sclerosis, cerebral palsy, stroke, traumatic brain injury, and alzheimer's disease.
ADDRESS
615 Arapeen Drive
Suite 102
Salt Lake City, UT 84108
United States
PHONE
1-801-582-5400
  • Deborah A Eppstein
    President/CEO
Show More